Dissemination of the metallo-β-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia

Clinical Infectious Diseases

Volumn 41, Issue 11, 2005, Pages 1549-1556

  Peleg, Anton Y ^a   Franklin, Clare ^a   Bell, Jan M ^b   Spelman, Denis W ^a  

^a ALFRED HOSPITAL   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; METALLO BETA LACTAMASE; POLYMYXIN; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLA IMP4 GENE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; DEATH; ENTEROBACTER CLOACAE; EPIDEMIC; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENE TRANSFER; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; INTEGRON; INTENSIVE CARE UNIT; INTI1 GENE; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RIBOTYPING; SEPTICEMIA; SEQUENCE ANALYSIS; SERRATIA MARCESCENS; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUSTRALIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 28044455209     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/497831     Document Type: Article

References (29)

1. Chu YW, Afzal-Shah M, Houang ET, et al. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob AgentsChemother 2001; 45:710-4.
2. VIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J Antimicrob Chemother 2004; 53:451-6.
3. Toleman MA, Biedenbach D, Bennett DM, Jones RN, Walsh TR. Italian metallo-β-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J Antimicrob Chemother 2005; 55:61-70.
4. IMP-7. Antimicrob Agents Chemother 2002; 46:255-8.
5. Toleman MA, Simm AM, Murphy TA, et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother 2002; 50:673-9.
6. Takahashi A, Yomoda S, Kobayashi I, Okubo T, Tsunoda M, Iyobe S. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J Clin Microbiol 2000; 38:526-9.
7. IMP) in gram-negative rods resistant to broad-spectrum β-lactams. J Clin Microbiol 1996; 34:2909-13.
8. IMP. Antimicrob Agents Chemother 1998; 42:2006-11.
9. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991; 35:147-51.
10. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18:306-25.
11. Hawkey PM, Xiong J, Ye H, Li H, M'Zali FH. Occurrence of a new metallo-beta-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China. FEMS Microbiol Lett 2001; 194:53-7.
12. IMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000. Antimicrob Agents Chemother 2003; 47:1382-90.
13. Fluit AC, Schmitz FJ. Resistance integrons and super-integrons. Clin Microbiol Infect 2004; 10:272-88.
14. Peleg AY, Franklin C, Bell J, Spelman DW Emergence of IMP-4 metallo-β-lactamase in a clinical isolate from Australia. J Antimicrob Chemother 2004; 54:699-700.
15. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, 6th ed. NCCLS Document M7-A6. Wayne, PA: NCCLS, 2003.
16. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI document M100-S-15. Wayne, PA: NCCLS, 2005.
17. Tsakris A, Pournaras S, Woodford N, et al. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol 2000; 38:1290-2.
18. Yan JJ, Hsueh PR, Ko WC, et al. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001; 45:2224-8.
19. Shibata N, Doi Y, Yamane K, et al. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J Clin Microbiol 2003; 41:5407-13.
20. Charles PG, Grayson ML. The dearth of new antibiotic development: why we should be worried and what we can do about it. Med J Aust 2004; 181:549-53.
21. Senda K, Arakawa Y, Nakashima K, et al. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob Agents Chemother 1996; 40:349-53.
22. IMP among clinically isolated strains of Serratia marcescens. Antimicrob Agents Chemother 1995; 39:824-9.
23. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34:634-40.
24. Yan JJ, Wu JJ, Tsai SH, Chuang CL. Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilli. Diagn Microbiol Infect Dis 2004; 49:5-11.
25. Bellais S, Mimoz O, Leotard S, Jacolot A, Petitjean O, Nordmann P. Efficacy of β-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-β-lactamase-producing strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002; 46:2032-4.
26. Cornaglia G, Mazzariol A, Lauretti L, Rossolini GM, Fontana R. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin Infect Dis 2000; 31:1119-25.
27. Lee NY, Yan JJ, Lee HC, Liu KH, Huang ST, Ko WC. Clinical experiences of bacteremia caused by metallo-β-lactamase-producing gram-negative organisms. J Microbiol Immunol Infect 2004; 37:343-9.
28. Hirakata Y, Yamaguchi T, Nakano M, et al. Clinical and bacteriological characteristics of IMF-type metallo-β-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis 2003; 37:26-32.
29. VIM-2 Cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob Agents Chemother 2002; 46:1053-8.